Does the FDG uptake of primary non-small cell lung cancer predict prognosis? A work in progress

Clinical Positron Imaging (Netherlands)

Volumn 2, Issue 2, 1999, Pages 111-118

  Sugawara, Yoshifumi ^a   Quint, Leslie E ^b   Iannettoni, Mark D ^b   Orringer, Mark B ^b   Russo, Joseph E ^a   Recker, Betty E ^a   Saran, Patricia A ^a   Wahl, Richard L ^a,b  

^a Division of General Medicine   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

2 fluorine 18 fluoro 2 deoxy D glucose (FDG); Emission Computed Tomography; Non small Cell Lung Cancer; Positron Emission Tomography (PET); Prognosis; Standardized Uptake Value (SUV)

Indexed keywords

EID: 0000716072     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00012-6     Document Type: Article

References (29)

1. S.H. Landis T. Murray S. Bolden P.A. Wingo Cancer statistics, 1998 CA Cancer J. Clin. 48 1998 6 29
2. R.J. Ginsberg E.E. Vokes A. Raben Non-small cell lung cancer V.T.J. DeVita S. Hellman S.A. Rosenberg Cancer principles & practice of oncology 1997 Lippincott-Raven Philadelphia
3. E.F. Patz Jr. V.J. Lowe J.M. Hoffman Focal pulmonary abnormalities evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
4. F.G. Duhaylongsod V.J. Lowe E.F. Patz Jr. A.L. Vaughn R.E. Coleman W.G. Wolfe Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography Ann. Thorac. Surg. 60 1995 1348 1352
5. V.J. Lowe J.W. Fletcher L. Gobar Prospective investigation of positron emission tomography in lung nodules J. Clin. Oncol. 16 1998 1075 1084
6. R.L. Wahl L.E. Quint R.L. Greenough C.R. Meyer R.I. White M.B. Orringer Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images preliminary prospective evaluation Radiology 191 1994 371 377
7. 18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group Ann. Thorac. Surg. 58 1994 698 703
8. M. Sasaki Y. Ichiya Y. Kuwabara The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer a comparative study with x-ray computed tomography Eur. J. Nucl. Med. 23 1996 741 747
9. J.F. Vansteenkiste S.G. Stroobants P.R. De Leyn Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer a prospective analysis of 50 cases Leuven Lung Cancer Group. Chest 112 1997 1480 1486
10. 18F-2-fluoro-2-deoxy- d -glucose and positron emission tomography preliminary study of lung cancer Int. J. Radiat. Oncol. Biol. Phys. 19 1990 1005 1010
11. Y. Ichiya Y. Kuwabara M. Sasaki A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma Ann. Nucl. Med. 10 1996 193 200
12. N.J. Patronas G. Di Chiro C. Kufta Prediction of survival in glioma patients by means of positron emission tomography J. Neurosurg. 62 1985 816 822
13. G. Di Chiro J. Hatazawa D.A. Katz H.V. Rizzoli D.J. De Michele Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence a PET study Radiology 164 1987 521 526
14. 18F]-fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool Invest. Radiol. 22 1987 360 371
15. J. Okada K. Yoshikawa K. Imazeki The use of FDG-PET in the detection and management of malignant lymphoma correlation of uptake with prognosis J. Nucl. Med. 32 1991 686 691
16. H. Minn M. Lapela P.J. Klemi Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer J. Nucl. Med. 38 1997 1907 1911
17. American Joint Committee on Cancer Lung O.H. Beahrs D.E. Henson R.V.P. Hutter B.J. Kennedy Manual for staging of cancer 1992 J.B. Lippincott Philadelphia
18. 18F]fluoro- d -glucose by direct nucleophilic exchange on a quaternary 4-aminopyridnium resin Int. J. Rad. Appl. Instrum. [B] 17 1990 273 279
19. K.R. Zasadny R.L. Wahl Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy- d -glucose variations with body weight and a method for correction Radiology 189 1993 847 850
20. B. Lippitz U. Cremerius L. Mayfrank PET-study of intracranial meningiomas correlation with histopathology, cellularity and proliferation rate Acta Neurochir. [suppl] 65 1996 108 111
21. H. Minn H. Joensuu A. Ahonen P. Klemi Fluorodeoxyglucose imaging a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors Cancer 61 1988 1776 1781
22. J. Okada K. Yoshikawa M. Itami Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma a comparison with proliferative activity J. Nucl. Med. 33 1992 325 329
23. M.F. Jefferson N. Pendleton E.B. Faragher G.R. Dixon M.W. Myskow M.A. Horan Tumor volume’ as a predictor of survival after resection of non-small-cell lung cancer (NSCLC) Br. J. Cancer 74 1996 456 459
24. J.C. Pence B.J. Kerns R.K. Dodge J.D. Iglehart Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer Arch. Surg. 128 1993 1382 1390
25. Y. Ichiya Y. Kuwabara M. Otsuka Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography J. Nucl. Med. 32 1991 1655 1660
26. T. Higashi K. Nakamura S. Suzuki J.R. Allison H. Wakao Ga-67 scan as a prognostic indicator in primary lung carcinoma Clin. Nucl. Med. 7 1982 553 557
27. H. Takekawa K. Takaoka E. Tsukamoto K. Kanegae F. Miller Y. Kawakami Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma Cancer 80 1997 198 203
28. T. Fujiwara T. Matsuzawa K. Kubota Relationship between histologic type of primary lung cancer and carbon-11- l -methionine uptake with positron emission tomography J. Nucl. Med. 30 1989 33 37
29. W.J. Shih U.Y. Ryo M.L. Dillon Carbon-11- l -methionine uptake with PET as a predictor of prognosis for bronchogenic carcinoma patients [letter; comment] J. Nucl. Med. 30 1989 1420 1422